Urologic complications after transplantation of 225 en bloc kidneys from small pediatric donors ≤20 kg: Incidence, management, and impact on graft survival
- PMID: 31984616
- DOI: 10.1111/ajt.15792
Urologic complications after transplantation of 225 en bloc kidneys from small pediatric donors ≤20 kg: Incidence, management, and impact on graft survival
Abstract
Pediatric en bloc kidney transplants (EBKs) from small deceased pediatric donors are associated with increased early graft loss and morbidity. Yet, urologic complications post-EBK and their potential impact on graft survival have not been systematically studied. We retrospectively studied urological complications requiring intervention for 225 EBKs performed at our center January 2005 to September 2017 from donors ≤20 kg into recipients ≥18 years. Overall ureteral complication incidence after EBK was 9.8% (n = 22) (12% vs 2% for EBK donors 10 vs 10 kg, respectively [P = .031]). The most common post-EBK urologic complication was a stricture (55%), followed by urine leak (41%). In all, 95% of all urologic complications occurred early within 5 months posttransplant (median, 138 days). Urologic complications could be successfully managed nonoperatively in 50% of all cases and had no impact on graft or patient survival. In summary, urologic complications after EBK were common, associated with lower donor weights, occurred early posttransplant, and were often amenable to nonoperative treatment, without adversely affecting survival. We conclude that the higher urologic complication rate after EBK (1) should not prevent increased utilization of small pediatric donor en bloc kidneys for properly selected recipients, and (2) warrants specific discussion with EBK recipients during the preoperative consent process.
Keywords: clinical research/practice; donors and donation: deceased; kidney (allograft) function/dysfunction; kidney transplantation/nephrology.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.
Comment in
-
Renal Transplantation and Renovascular Hypertension.J Urol. 2021 Apr;205(4):1214-1215. doi: 10.1097/JU.0000000000001610. Epub 2021 Jan 21. J Urol. 2021. PMID: 33472373 No abstract available.
References
REFERENCES
-
- Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-1730.
-
- Reese PP, Shults J, Bloom RD, et al. Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates. Am J Kidney Dis. 2015;66(5):837-845.
-
- Waitlist removals-Kidney. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/. Accessed October 5, 2019.
-
- Perez RV, Santhanakrishnan C, de Mattos A, McVicar J, Troppmann C. The neonatal intensive care unit (NICU) as a source of deceased donor kidneys for transplantation: initial experience with 20 cases. Am J Transplant. 2014;14(suppl 3):134.
-
- Wijetunga I, Ecuyer C, Martinez-Lopez S, et al. Renal transplant from infant and neonatal donors is a feasible option for the treatment of end-stage renal disease but is associated with increased early graft loss. Am J Transplant. 2018;18(11):2679-2688.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical